CNS Pharmaceuticals Inc (CNSP) — Financial Flexibility Index
CNS Pharmaceuticals Inc (CNSP) has a Financial Flexibility Index of -1.01x as of March 2026. Free cash flow of $-4.64 Million (operating CF $-4.65 Million minus capex $6.18K) represents -1% of total liabilities ($4.58 Million). Check asset allocation strategy of CNS Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
CNS Pharmaceuticals Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for CNS Pharmaceuticals Inc across 9 annual periods. See CNSP working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for CNS Pharmaceuticals Inc (2017–2025)
Year-by-year free cash flow to debt coverage for CNS Pharmaceuticals Inc. For the full company profile including market capitalisation, see market cap of CNS Pharmaceuticals Inc.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.36x | $-13.79 Million | $-13.81 Million | $4.10 Million | ▲ +50.4% |
| 2024 | -6.78x | $-17.11 Million | $-17.11 Million | $2.52 Million | ▼ -194.0% |
| 2023 | -2.30x | $-14.14 Million | $-14.14 Million | $6.13 Million | ▼ -7.5% |
| 2022 | -2.14x | $-10.55 Million | $-10.56 Million | $4.92 Million | ▲ +66.2% |
| 2021 | -6.34x | $-13.53 Million | $-13.54 Million | $2.14 Million | ▼ -65.4% |
| 2020 | -3.83x | $-7.30 Million | $-7.32 Million | $1.91 Million | ▲ +66.3% |
| 2019 | -11.36x | $-3.53 Million | $-3.55 Million | $311.00K | ▼ -1854.9% |
| 2018 | -0.58x | $-716.38K | $-716.38K | $1.23 Million | ▼ -14.3% |
| 2017 | -0.51x | $-112.19K | $-112.20K | $220.73K | — |